Psychedelics News September 2020

One psychedelics company reaches the 3-comma club, another releases the second large app. Psychedelics can help with pain, demoralization (for AIDS survivors), and eating disorders – as preliminary research is showing. And the money keeps flowing towards research with the launch of UC Berkeley’s own psychedelic research lab and Dr Bronner’s continued commitment to the cause.

Psychedelics News August 2020

News about psychedelics hasn’t slowed down a bit during August. Everyone was delighted by the news that MAPS raised the $30 million they need to get MDMA-assisted psychotherapy through Phase III of FDA trials. Within a span of 6 months, they were able to raise this money from both large (from both aisles) and small donors (2700 in total).

Psychedelics News July 2020

This month starts with a feature of Psychedelic Science Review which has ramped up their reporting and translation of scientific papers to understandable blogs. Companies in the psychedelic space continue to release news, but most of it is about acquisitions, not much is about trial outcomes.

Psychedelics News June 2020

As the world is still in partial lockdown, the psychedelics field seems to be evolving quicker than ever before. Much of the news below is related to the plans of companies. Some good news also comes from NGOs as MAPS is fundraising and support for psychedelics is growing in the US and Canda.

Psychedelics News May 2020

May has been a busy month. One that saw more continued investments, a call for an ethics guide, and interesting results from the largest DMT survey to this date.

Psychedelics News April 2020

Psilocybin has been made in yeast in the lab, which could mean even easier (and more accessible) production and distribution of it in the future. A lot of companies keep expanding and MindMed takes the headline a few times. A lot of the research is taking a pause, as COVID-19 ravages through the world.